Aquestive Therapeutics (AQST) Shares Outstanding (Diluted) (2018 - 2026)
Aquestive Therapeutics (AQST) posted Weighted Average Shares Outstanding (Diluted) of 125.55 million for Q3 2026, up 13.5% from 110.58 million a year earlier and up 0.4% from the prior quarter.
Powered by 
Analysis
Aquestive Therapeutics (AQST) Shares Outstanding (Diluted) (2018 - 2026) Analysis & Trends
For FY2025, Aquestive Therapeutics' Weighted Average Shares Outstanding (Diluted) came in at 106.93 million, up 23.3% from FY2024.
- Annual Weighted Average Shares Outstanding (Diluted) has increased for five consecutive years, with a five-year compound annual growth rate of 26.0% (FY2020 to FY2025).
- In prior years, Aquestive Therapeutics' Weighted Average Shares Outstanding (Diluted) was 86.73 million in FY2024 (+41.6%), 61.26 million in FY2023 (+25.7%), 48.73 million in FY2022 (+28.0%) and 38.08 million in FY2021 (+13.2%).
- The Q3 2026 figure stands as the highest quarterly Weighted Average Shares Outstanding (Diluted) in data going back to Q1 2020.
- On a year-over-year basis, Weighted Average Shares Outstanding (Diluted) has increased in each of the last ten quarters, with growth averaging 24.1% over the last eight quarters.
- The strongest year-over-year quarter for Weighted Average Shares Outstanding (Diluted) in the past five years was Q1 2023, with growth of 78.0%; the weakest was Q1 2024, with a decline of 0.2%.
- According to Business Quant data, Weighted Average Shares Outstanding (Diluted) for the three prior quarters was 124.99 million (Q2 2026), 122.61 million (Q1 2026) and 106.93 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 893.40 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.45 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.48 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 1.96 Bn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 1.56 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 546.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.25 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.75 Bn |
| 10 | Aquestive Therapeutics | 442.42 Mn | 21.68 Mn | 3.95 Mn | 125.55 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 125.55 Mn |
| Jun 30, 2026 | 124.99 Mn |
| Mar 31, 2026 | 122.61 Mn |
| Dec 31, 2025 | 106.93 Mn |
| Sep 30, 2025 | 110.58 Mn |
| Jun 30, 2025 | 99.33 Mn |
| Mar 31, 2025 | 95.50 Mn |
| Dec 31, 2024 | 86.73 Mn |
| Sep 30, 2024 | 91.08 Mn |
| Jun 30, 2024 | 90.91 Mn |
| Mar 31, 2024 | 73.61 Mn |
| Dec 31, 2023 | 61.26 Mn |
| Sep 30, 2023 | 64.68 Mn |
| Jun 30, 2023 | 57.35 Mn |
| Mar 31, 2023 | 73.79 Mn |
| Dec 31, 2022 | 48.73 Mn |
| Sep 30, 2022 | 53.42 Mn |
| Jun 30, 2022 | 45.46 Mn |
| Mar 31, 2022 | 41.47 Mn |
| Dec 31, 2021 | 38.08 Mn |
API Access
Aquestive Therapeutics Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=AQST&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "AQST", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=AQST&period=max&api_key=YOUR_API_KEY");
const data = await res.json();